findmyKOL
Clinical trialNCT02575794CompletedPhase 1Interventional

Terameprocol in Treating Patients With Recurrent High Grade Glioma

SponsorSidney Kimmel Comprehensive Cancer Center at Johns HopkinsEnrollment20High Grade Glioma (III or IV)
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Uab Comprehensive Cancer Center

    Birmingham, Alabama, United States

  • Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

    Baltimore, Maryland, United States

  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

  • Josephine Ford Cancer Center at Henry Ford Hospital

    Detroit, Michigan, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, United States

  • Wake Forest University Comprehensive Cancer Center

    Winston-Salem, North Carolina, United States

  • Cleveland Clinic Taussig Cancer Center

    Cleveland, Ohio, United States

  • Abrams Cancer Center of the University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Hillman Cancer Center at University of Pittsburgh Cancer Institute

    Pittsburgh, Pennsylvania, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Terameprocol
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
3 May 2018
Primary completion
30 Sept 2023
Completion
4 Oct 2023
Last update posted
6 Oct 2023
Registered enrollment
20
Registry id
NCT02575794
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.